← FDA DRUG APPROVALS

FDA ANDA · ANDA072354

DESONIDE

Sponsor: GALDERMA LABS LP

APPLICATION
ANDA072354
TYPE
ANDA
ORIGINAL APPROVAL
1992-01-24
LATEST ACTION
2015-04-13
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Discontinued

Products

DESOWENDiscontinued
DESONIDE 0.05% · LOTION · TOPICAL

Approval history

2015-04-13Labeling · Supplement 9 · standardAP
1998-06-12Labeling · Supplement 6AP
1998-06-12Manufacturing (CMC) · Supplement 5AP
1995-07-28Labeling · Supplement 4AP
1995-07-28Manufacturing (CMC) · Supplement 3AP
1994-11-01Manufacturing (CMC) · Supplement 2AP
1993-05-19Labeling · Supplement 1AP
1992-01-24OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →